EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Artificial intelligence and melanoma: a systematic review of clinical applications

Gloria María Neyra Mondoñedo, Desiree Acosta de la Cruz, Andreia Borges Scriboni

MedNEXT Journal of Medical and Health Sciences · 21.10.2026 · 7 (4)

DOI: 10.54448/mdnt26403 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift MedNEXT Journal of Medical and Health Sciences, online erschienen am 21.10.2026. Verfasst von Gloria María Neyra Mondoñedo und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

New therapeutic perspectives for cancer treatment have focused on precision medicine, personalized to the patient's characteristics. Artificial intelligence (AI) allows the combination of all this data to obtain new information about the possible prognosis and treatment of patients. Metastatic melanoma is one of the pathologies that seems to benefit from modern mathematical and computational data processing approaches.

Objective

It was to develop a systematic review of the clinical applications of artificial intelligence in the identification and treatment of melanoma.

Methods

The systematic review rules of the PRISMA Platform were followed. The search was conducted from May to August 2026 in the Web of Science, Scopus, PubMed, Science Direct, SciELO, and Google Scholar databases. The quality of the studies was based on the GRADE and AMSTAR-2 instruments, and the risk of bias was adequately analyzed according to the Cochrane instrument. Results and Conclusion: 82 articles were found. A total of 28 articles were qualitatively evaluated, and 11 were included and developed in this systematic review study. Clinical studies showed homogeneity in their results, with Chi-Square (X2) = 81.4% > 50%. Considering the Cochrane tool for risk of bias, the overall assessment resulted in 14 studies with a high risk of bias and 30 studies that did not meet the GRADE and AMSTAR-2 criteria. It was concluded that AI enables a more precise approach to the diagnosis and treatment guidance of melanoma. This will result in improvements in administration, time, and costs related to patient management. Furthermore, the incorporation of all these complex analyses into clinical practice could certainly implement the myriad of information we have about individual diseases, contributing to the creation of updated databases designed to stratify patients and assist the physician in choosing the most appropriate diagnosis and treatment for each patient. With important initial objectives achieved, further research is needed to ensure the analytical and clinical validity of AI approaches.

Zitieren

APA

Mondoñedo, G. M. N., Cruz, D. A. D. L., & Scriboni, A. B. (2026). Artificial intelligence and melanoma: a systematic review of clinical applications. MedNEXT Journal of Medical and Health Sciences, 7(4). https://doi.org/10.54448/mdnt26403

Vancouver

Mondoñedo GMN, Cruz DADL, Scriboni AB. Artificial intelligence and melanoma: a systematic review of clinical applications. MedNEXT Journal of Medical and Health Sciences. 2026;7(4). doi:10.54448/mdnt26403

BibTeX
@article{Mondoedo2026,
  author = {Mondoñedo, Gloria María Neyra and Cruz, Desiree Acosta de la and Scriboni, Andreia Borges},
  title = {Artificial intelligence and melanoma: a systematic review of clinical applications},
  journal = {MedNEXT Journal of Medical and Health Sciences},
  year = {2026},
  volume = {7},
  number = {4},
  doi = {10.54448/mdnt26403}
}
Kostenlos starten →